In the current study, we analyzed the activity of SR and hnRNP proteins in the context of SMN2 splicing in order to further characterize the regulatory roles these proteins may play in SMA disease pathogenesis and to identify potential targets for therapeutics. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.